Sunday, June 21, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 784 of 1,261

  1. US 8877161

    GM1-like peptides and uses thereof

    Georgia Regents Research Institute, Inc. · Granted Nov 4, 2014 · Expires Oct 30, 2034

    granted

  2. US 8875970

    Structure containing wound treatment material

    Covidien LP · Granted Nov 4, 2014 · Expires Oct 30, 2034

    granted

  3. US 8877188

    Detection and treatment of non-dermal fibrosis

    The Board of Regents of the University of Texas System · Granted Nov 4, 2014 · Expires Oct 30, 2034

    granted

  4. US 8877206

    Stimulation of an immune response by cationic lipids

    PDS Biotechnology Corporation · Granted Nov 4, 2014 · Expires Oct 30, 2034

    granted

  5. US 8877208

    Multivalent nanoemulsion vaccines

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Nov 4, 2014 · Expires Oct 30, 2034

    granted

  6. US 8877213

    Live attenuated Leishmania vaccines

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Nov 4, 2014 · Expires Oct 30, 2034

    granted

  7. US 8877199

    B cell surface reactive antibodies

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Nov 4, 2014 · Expires Oct 30, 2034

    granted

  8. US 8877204

    Methods and compositions for the treatment of cancer and infectious disease using alpha (2) macroglobulin-antigenic molecule complexes

    University of Connecticut Health Center · Granted Nov 4, 2014 · Expires Oct 30, 2034

    granted

  9. US 8877248

    Sustained-release formulations of topiramate

    Supernus Pharmaceuticals, Inc. · Granted Nov 4, 2014 · Expires Oct 30, 2034

    granted

  10. US 8877215

    Compounds with modifying activity enhanced under hypoxic conditions

    The Board of Regents of the University of Texas System · Granted Nov 4, 2014 · Expires Oct 30, 2034

    granted

  11. US 8877253

    Cellular extracts

    REGENICS AS · Granted Nov 4, 2014 · Expires Oct 30, 2034

    granted

  12. US 8877725

    Peptide conjugated, inosine-substituted antisense oligomer compound and method

    Sarepta Therapeutics, Inc. · Granted Nov 4, 2014 · Expires Oct 30, 2034

    granted

  13. US 8877721

    Small activating RNA molecules and methods of use

    The Regents of the University of California · Granted Nov 4, 2014 · Expires Oct 30, 2034

    granted

  14. US 8877195

    Monoclonal antibodies to fibrin

    The Regents of the University of California · Granted Nov 4, 2014 · Expires Oct 30, 2034

    granted

  15. EP 2796145

    EIN KOVALENTER KOMPLEX BESTEHEND AUS VON WILLEBRAND UND FAKTOR VIII VERBUNDEN MIT EINER DISULFIDBRÜCKE

    CSL BEHRING GMBH [DE] · Granted Oct 29, 2014 · Expires Oct 24, 2034

    granted

  16. US 8871191

    Use of IL-15 preparations to treat lymphopenia

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Oct 28, 2014 · Expires Oct 23, 2034

    granted

  17. US 8871792

    Neprilysin inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Oct 28, 2014 · Expires Oct 23, 2034

    granted

  18. US 8871273

    Method for producing granules

    Takeda Pharmaceutical Company Limited · Granted Oct 28, 2014 · Expires Oct 23, 2034

    granted

  19. US 8871199

    Compositions and methods to promote implantation and engrafment of stem cells

    REGENERATIVE SCIENCES, LLC · Granted Oct 28, 2014 · Expires Oct 23, 2034

    granted

  20. US 8871209

    Compositions and methods for increasing muscle mass and muscle strength by specifically antagonizing GDF8 and or Activin A

    REGENERON PHARMACEUTICALS, INC. · Granted Oct 28, 2014 · Expires Oct 23, 2034

    granted

  21. US 8871774

    Inhibitors of influenza viruses replication

    Vertex Pharmaceuticals Incorporated · Granted Oct 28, 2014 · Expires Oct 23, 2034

    granted

  22. US 8871766

    Heterocyclic compounds

    Takeda Pharmaceutical Company Limited · Granted Oct 28, 2014 · Expires Oct 23, 2034

    granted

  23. US 8871447

    Immunogens and corresponding antibodies specific for high molecular weight aggregation intermediates common to amyloids formed from proteins of differing sequence

    The Regents of the University of California · Granted Oct 28, 2014 · Expires Oct 23, 2034

    granted

  24. US 8871487

    Compositions, methods and uses for inducing viral growth

    Takeda Vaccines, Inc. · Granted Oct 28, 2014 · Expires Oct 23, 2034

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.